INTRODUCTION
Aluminum phosphide (AlP) is a commonly used cheap rodenticide, insecticide, and fumigant. 3-gram AlP tablets are widely used in grain storage. AlP is a common cause of acute chemical toxicity, particularly in India and Iran. 1 Intoxication has high mortality and a dose between 150 and 500 mg is lethal for a 70-kg person. Most intoxications in the literature are of suicidal ingestions; however, AlP may cause incidental inhalational toxicities as well. 2 There is no specifi c antidote or treatment for AlP toxicity. Many different approaches are reported in the literature, such as countering oxidative injury by using antioxidants, hyperbaric oxygen therapy or gastric irrigation with different compounds to reduce absorption of toxic compounds, and hemodynamic supportive care. 3 However, all these approaches are non-specifi c and have limited effi cacy.
In Turkey, AlP tablets are widely accessible and are sold without any restrictions. However, there are few local case reports in the literature. Additionally, incidental AlP intoxications are rarely reported. Herein, we present a case of a 25-year-old male patient incidentally poisoned with AlP, our treatment approach and current literature regarding pathogenesis and treatment. 
CASE REPORT

DISCUSSION
AlP is a widely available and highly toxic pesticide. When the compound comes in contact with water, it quickly dissolves, emitting phosphine (PH3) gas, which is colorless, odorless, fl ammable, and highly toxic. 1 After suicidal or accidental ingestion or inhalation, PH3 gas is absorbed rapidly through the mucosa, causing nausea, vomiting, dyspnea and abdominal pain within minutes. Refractory hypotension, cardiac failure, and severe metabolic acidosis within a matter of hours are the hallmarks of toxicity and the major cause of mortality. [2] [3] [4] [5] [6] Exact mechanism of AlP toxicity is not clearly understood, however, major mechanisms of toxicity are: (a) mitochondrial toxicity characterized by cytochrome C oxidase inhibition, subsequently interfering with electron transfer between complex III to complex IV resulting in energy depletion, (b) oxidative injury and lipid peroxidation causing cellular injury, and (c) oxidative mechanisms causing protein denaturation and cellular membrane injury. [2] [3] [4] Treatment is based on best supportive care. Reducing absorption of AlP is one of the possible approaches to reduce mortality. Gastric lavage with potassium permanganate, sodium bicarbonate, and activated charcoal was routinely performed to counterbalance the toxic effects in AlP toxicity in the past. Potassium permanganate can change phosphide to less toxic compounds and bicarbonate can reduce gastrointestinal secretions which would reduce PH3 release. In addition, activated charcoal can absorb phosphine gas. [6] [7] [8] [9] Although the exact time of toxicity was not known, we performed gastric lavage with potassium permanganate and sodium bicarbonate. Rapid use of activated charcoal and gastric lavage with potassium permanganate and sodium bicarbonate can potentially be used in patients with AlP toxicity.
Another point to consider in treating AlP toxicity is to counter oxidative injury using antioxidants. One such study compared the administration of vitamin E against placebo, in which vitamin E administration signifi cantly increased blood pressure and reduced mortality in treatment group. 1 Taghaddosinejad et al. demonstrated possible protective effects of n-acetyl cysteine on cardiovascular complications by a similar mechanism. 10 We used n-acetyl cysteine in the present case as an antioxidant to counter oxidative injury. Even though AlP poisoning is not solely due to increased oxidation status, antioxidants seem to have a benefi cial role in treatment and should be considered in treatment algorithm.
The most common symptom and cause of mortality in AlP poisoning is severe hypotension. It is commonly refractory to massive crystalloid administration and vasoactive agents such as norepinephrine or dopamine. 6 We administered a crystalloid solution with norepinephrine infusion in this case and fortunately, the patient recovered from hypotension quickly. However, even with the use of vasoactive agents, hypotension may persist due to insufficient vascular integrity. Volume expanders such as hydroxyethyl starch may be successfully used to prevent mortality in such cases, however, possible side effects such as renal failure and coagulopathy should be kept in mind. 5 Other major causes of mortality in AlP toxicity are severe metabolic acidosis and cardiogenic shock, which are possibly caused by cytochrome C oxidase inhibition and generalized tissue hypoperfusion. Cardiogenic shock in AlP poisoning is mainly characterized by pump failure. Tissue hypoperfusion and acidosis may further reduce cardiac output as well. In addition, common electrolyte abnormalities such as hypokalemia and hypocalcemia also infl uence the cardiac functions. 6 Hyperlactatemia, a result of energy insuffi ciency and tissue hypoperfusion, was shown to be a prognostic marker in acute AlP poisoning. 11 Our patient did not develop acidosis, electrolyte abnormalities or cardiogenic shock, possibly due to rapid recovery. When it occurs, a range of options exist to treat cardiogenic shock, such as intra-aortic balloon pump, extracorporeal membrane oxygenation, digitalis, trimetazidine and glucose/ insulin infusions. [11] [12] [13] Sodium bicarbonate treatment may be arguably helpful in such cases to counteract severe acidosis, however, improving cardiac output to reduce hypoperfusion and related hyperlactatemia, should be the main purpose.
Herein, we reported an incidental case of AlP poisoning. AlP is a widely available pesticide and a common cause of toxicity and to date, there is no specifi c antidote or treatment for AlP toxicity. Fortunately, our patient responded well to conventional supportive care. However, literature is controversial regarding the treatment approach in refractory cases. In Turkey, AlP tablets are widely accessible and are sold without any restrictions. However, there are few local case reports in the literature. Preventive strategies, such as promoting local legislations to ban or restrict AlP sale should be considered to reduce incident of suicidal ingestions or possible biochemical terrorism acts in regions of high incidence. Additionally, clinicians should also be aware that AlP is a widely available and highly toxic compound that has no specifi c antidote and toxicity needs to be urgently treated with best supportive care. Inhalational toxicity may occur under extreme conditions, as presented in this case report. Volume expanders to treat severe hypotension, antioxidants to counter oxidative status, and treatment options to increase cardiac output such as intra-aortic balloon pump, extracorporeal membrane oxygenation, and digitalis, trimetazidine and glucose/ insulin infusion should be kept in mind in patients with severe AlP toxicity.
